A detailed history of Sanctuary Advisors, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Sanctuary Advisors, LLC holds 9,705 shares of EXAS stock, worth $650,526. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,705
Previous 11,103 12.59%
Holding current value
$650,526
Previous $590 Million 28.79%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Jan 06, 2026

SELL
$40.91 - $56.0 $57,192 - $78,288
-1,398 Reduced 12.59%
9,705 $420 Million
Q2 2025

Jan 06, 2026

BUY
$40.31 - $58.08 $56,353 - $81,195
1,398 Added 14.4%
11,103 $590 Million
Q1 2025

Jan 06, 2026

SELL
$43.04 - $58.51 $168,716 - $229,359
-3,920 Reduced 28.77%
9,705 $420 Million
Q4 2024

Jan 31, 2025

BUY
$49.33 - $71.97 $13,269 - $19,359
269 Added 2.01%
13,625 $763 Million
Q3 2024

Nov 25, 2024

BUY
$42.43 - $70.83 $566,695 - $946,005
13,356 New
13,356 $707 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Sanctuary Advisors, LLC Portfolio

Follow Sanctuary Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanctuary Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanctuary Advisors, LLC with notifications on news.